Prosecution Insights
Last updated: July 17, 2026

Nutrition & Biosciences USA

7 pending office actions • 5 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
6
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (86%)
1
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (86%)
Double-patenting only1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
86% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OLSON, ANDREA STEFFEL 2 62.3% -12.2%
FORTUNA, JOSE A 1 79.5% +9.7%
SILVERMAN, JANICE Y 1 36.5% +53.3%
GREENE, IVAN A 1 18.7% +6.2%
MCINTOSH III, TRAVISS C 1 73.2% +14.1%
KUMAR, PREETI 1 31.3% +44.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18576406 CATIONIC GLUCAN ESTER DERIVATIVES GREENE, IVAN A 70d

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18495216 NONWOVEN GLUCAN WEBS MCINTOSH III, TRAVISS C 14d
18695603 OPTIMIZED WATER LINE DELIVERY OF MICROBES SILVERMAN, JANICE Y 70d
18008213 POLY ALPHA-1,6-GLUCAN ESTERS AND COMPOSITIONS COMPRISING SAME KUMAR, PREETI

Top Art Units

Art UnitApps
1693 2
1748 1
1792 1
1619 1
1761 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18727396 PAPER COATING COMPOSITIONS COMPRISING RUBBER AND INSOLUBLE ALPHA-GLUCAN FORTUNA, JOSE A 1748 §103 Final Rejection Pending Jul 09, 2024
18704557 COMPOSITIONS COMPRISING CATIONIC ALPHA-1,6-GLUCAN DERIVATIVE AND ALPHA-1,3-GLUCAN OLSON, ANDREA STEFFEL §103 Non-Final OA Pending Apr 25, 2024
18695603 OPTIMIZED WATER LINE DELIVERY OF MICROBES SILVERMAN, JANICE Y 1792 §103 Non-Final OA 70d Pending Mar 26, 2024
18604878 ALPHA-1,3-GLUCAN GRAFT COPOLYMERS OLSON, ANDREA STEFFEL 1693 DP Non-Final OA Pending Mar 14, 2024
18576406 CATIONIC GLUCAN ESTER DERIVATIVES GREENE, IVAN A 1619 §103 Non-Final OA 70d Pending Jan 04, 2024
18495216 NONWOVEN GLUCAN WEBS MCINTOSH III, TRAVISS C 1693 §103 Non-Final OA 14d Pending Oct 26, 2023
18008213 POLY ALPHA-1,6-GLUCAN ESTERS AND COMPOSITIONS COMPRISING SAME KUMAR, PREETI 1761 §103 Non-Final OA Pending Dec 05, 2022

Managing Nutrition & Biosciences USA's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month